Tag: Business
The Main Target and Focus: The article focuses on key figures attending the J.P....
Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures...
Unveiling JPM Day 1: A Comprehensive Overview for Investors
Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech...
Brian Thompson: The Rise and Fall of UnitedHealthcare’s CEO
MAPLE GROVE, Minn. - On a fateful day in New York City, the world lost Brian Thompson, the esteemed CEO of UnitedHealthcare. Thompson's journey...
Medicare Obesity Drug Coverage and 340B Analysis: Pharmalittle Updates
Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As...
AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger
Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay...
Biotech News Roundup: Stay Updated on the Latest Developments in the Industry
Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs...
Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know
Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally,...
FAQs: Understanding IGAs in Animals
Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA...
Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment
Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not...
Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker
Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia....
Apellis Triumphs while Astellas Faces Defeat
Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless...
RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability
Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
